New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Glanbia Nutritionals launches omega-3 powder

Glanbia Nutritionals launches omega-3 powder
The new product is a free-flowing omega-3 powder that the company says improves upon current product challenges with auto-oxidation, limited shelf-life, sensitivities to air, heat, light and humidity, and the potential to cause "fish-burps."

Glanbia Nutritionals, a premier global ingredient solutions and precision nutrient premix service provider, is pleased to announce the addition of OmniMEGA™ Advanced Omega-3 Powder to its growing proprietary ingredient portfolio. OmniMEGA™ is a patented, free-flowing omega-3 powder, offering multiple advantages over standard fish and krill oils with the ability to formulate into multi-ingredient tablet, capsule, melt and powdered beverage applications.  

OmniMEGA™'s enhanced composition provides clear benefits over current omega-3 delivery technologies that exhibit issues with auto-oxidation, limited shelf-life, sensitivities to air, heat, light and humidity, and the potential to cause "fish-burps." OmniMEGA™ comprises omega-3 fatty acids from fish oil that are bound to a beta cyclodextrin backbone, making a compressible powder suitable for tableting and ready-to-mix formulations that is more shelf stable, with less sensitivity to air and oxidation, without the fishy reflux. OmniMEGA™ is also GRAS and holds two WO process patents.

OmniMEGA™ studies have shown positive results in many areas with a bioavailability human clinical study showing that OmniMEGA™ tablets offer superior EPA and DHA absorption compared to soft-gels. In long-term accelerated stability studies OmniMEGA™ powder was shown to have excellent stability and shelf-life. Three unique studies assessed the occurrence of reflux eight to 24 hours after consuming OmniMEGA™ tablets compared to omega-3 soft-gel capsules, with the results showing no reflux occurring from consumption of OmniMEGA™ tablets.

“The addition of OmniMEGA™ Advanced Omega-3 Powder to Glanbia Nutritionals’ portfolio of premier ingredients provides customers the ability to formulate an omega-3 in to a powdered multi-ingredient application such as direct compressible tablets, capsules, ready-to-mix powdered beverages for sports nutrition and rapid melts as an alternative to children’s gummies.  OmniMEGA™ further expands the innovative ingredient options Glanbia Nutritionals offers for inclusion in supplements,” said Ram Nimmagudda, Ph.D., director of business development for Glanbia Nutritionals. 

OmniMEGA™ is an innovative ingredient for a growing omega-3 market and will add to Glanbia Nutritionals’ proprietary portfolio of nutrient solutions, supporting Glanbia’s strength as the leader in clinically-driven specialty ingredients.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.